Literature DB >> 15006962

Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma.

Bruno Mahut1, Christophe Delacourt, Françoise Zerah-Lancner, Jacques De Blic, Alain Harf, Christophe Delclaux.   

Abstract

STUDY
OBJECTIVES: To determine respective contributions of alveolar and proximal airway compartments in exhaled nitric oxide (NO) output (QNO) in pediatric patients with asthma and to correlate their variations with mild symptoms or bronchial obstruction. PATIENTS AND
DESIGN: In 15 asthmatic children with recent mild symptoms, 30 asymptomatic asthmatic children, and 15 healthy children, exhaled NO concentration was measured at multiple expiratory flow (V) rates allowing the calculation of alveolar and proximal airway contributions in QNO, using two approaches, ie, linear and nonlinear models. MEASUREMENTS AND
RESULTS: Asymptomatic and recently symptomatic patients were not significantly different regarding FEV(1) and maximum V between 25% and 75% of FVC (MEF(25-75)): FEV(1), 93.3 +/- 13.4% vs 90 +/- 7.5%; MEF(25-75), 70 +/- 22% vs 68 +/- 28% of predicted values, respectively (mean +/- SD). Maximal airway QNO output was significantly higher in recently symptomatic vs asymptomatic patients (p < 0.0001), and in asymptomatic patients vs healthy children (p < 0.02): 134 +/- 7 nl/min, 55 +/- 43 nl/min, and 19 +/- 8 nl/min, respectively. In a multiple regression analysis, variables that influenced airway QNO output were symptoms (p < 0.0001) and distal airway obstruction as assessed by MEF(25-75) (p < 0.05). Alveolar NO concentration (FANO) was significantly (p < 0.03) higher in recently symptomatic than in patients without symptoms, whereas it was not significantly different between asymptomatic patients and healthy children: 7.2 +/- 2.4 parts per billion (ppb), 5.5 +/- 2.7 ppb, and 4.2 +/- 2.0 ppb, respectively.
CONCLUSIONS: An increase in FANO was observed in the presence of symptoms, and proximal airway NO output was correlated with distal obstruction during asthma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006962     DOI: 10.1378/chest.125.3.1012

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Clinical study of multiple breath biomarkers of asthma and COPD (NO, CO(2), CO and N(2)O) by infrared laser spectroscopy.

Authors:  Joanne H Shorter; David D Nelson; J Barry McManus; Mark S Zahniser; Susan R Sama; Donald K Milton
Journal:  J Breath Res       Date:  2011-07-15       Impact factor: 3.262

2.  Optimal flow rate sampling designs for studies with extended exhaled nitric oxide analysis.

Authors:  Noa Molshatski; Sandrah P Eckel
Journal:  J Breath Res       Date:  2017-02-22       Impact factor: 3.262

3.  Multicomponent Breath Analysis With Infrared Absorption Using Room-Temperature Quantum Cascade Lasers.

Authors:  Joanne H Shorter; David D Nelson; J Barry McManus; Mark S Zahniser; Donald K Milton
Journal:  IEEE Sens J       Date:  2009-12-11       Impact factor: 3.301

4.  Clinical patterns in asthma based on proximal and distal airway nitric oxide categories.

Authors:  James L Puckett; Richard W E Taylor; Szu-Yun Leu; Olga L Guijon; Anna S Aledia; Stanley P Galant; Steven C George
Journal:  Respir Res       Date:  2010-04-28

Review 5.  Partitioned exhaled nitric oxide to non-invasively assess asthma.

Authors:  James L Puckett; Steven C George
Journal:  Respir Physiol Neurobiol       Date:  2008-07-31       Impact factor: 1.931

6.  Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.

Authors:  Arthur F Gelb; Colleen Flynn Taylor; Chris M Shinar; Carlos A Gutierrez; Noe Zamel
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

7.  Fractionated breath condensate sampling: H(2)O(2) concentrations of the alveolar fraction may be related to asthma control in children.

Authors:  Jordis Trischler; Nick Merkel; Stephanie Könitzer; Christina-Maria Müller; Susanne Unverzagt; Christiane Lex
Journal:  Respir Res       Date:  2012-02-14

8.  Exhaled nitric oxide and clinical phenotypes of childhood asthma.

Authors:  Bruno Mahut; Séverine Peyrard; Christophe Delclaux
Journal:  Respir Res       Date:  2011-05-20

9.  Reference values for exhaled nitric oxide (reveno) study.

Authors:  Mario Olivieri; Giorgio Talamini; Massimo Corradi; Luigi Perbellini; Antonio Mutti; Claudio Tantucci; Mario Malerba
Journal:  Respir Res       Date:  2006-06-30

10.  Breath acetone monitoring by portable Si:WO3 gas sensors.

Authors:  Marco Righettoni; Antonio Tricoli; Samuel Gass; Alex Schmid; Anton Amann; Sotiris E Pratsinis
Journal:  Anal Chim Acta       Date:  2012-06-12       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.